Delivery Order SPE2DR25D1053-SPE2DR26FT669
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,331.47 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (60-count inhalers), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This non-competitive delivery order, issued on November 10, 2025, with completion expected by November 12, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award was fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,817.91 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count package), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by November 10, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,796.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a delivery order valued at $6,173.80 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation medication used in respiratory disease management. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. Performance is to be completed by November 14, 2025, with the product delivered to Conshohocken, Pennsylvania, the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,668.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a completion date of November 17, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations for federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,897.40 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $5,101.16 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on December 1, 2025, with a completion deadline of December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a continuation of the company's pharmaceutical supply services to federal military and healthcare systems. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $39,150.40 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price contract is set to be completed by November 19, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT669Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,073.07 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price, competitively awarded delivery order was issued on November 6, 2025, with a completion date of November 7, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order represents one of numerous pharmaceutical procurement transactions executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and affiliated government healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Pennsylvania and serving as a major pharmaceutical distributor, holds significant capability to meet federal medical procurement requirements through its established relationships with the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 11/6/25 |